{"name":"Eutilex","slug":"eutilex","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOUUM5ZTAzN01Pc3pXZ242a0kxcXQ1TlBmX3h2SlJvcGFWQUhqN1dpS2tfQU5QMFlYM09DZUctQXdtU0VUMDNCWkJpSnRabU96UFEzQUw1Y2hacmVkVHZVZzlJX3BSRlo3a3FLRkJlejRLMTZESWJkV0Q5bnZZa0FaaXNZRTJuaEJheDdXa3VWM0lJVkN1bHBKWk16M2UzLUNiVndZSUFEbVJjcXlMQUhyamZqZC1Sa0VnSy1qQ3BMSlF2XzZ0UVJxRTNnOFEzZm9lN3VrQzQyWndCVmJnT3BNMA?oc=5","date":"2025-11-25","type":"pipeline","source":"ascopost.com","summary":"Ivonescimab, a Dual-Targeting Bispecific Antibody, Improves Progression-Free Survival in Squamous NSCLC - ascopost.com","headline":"Ivonescimab, a Dual-Targeting Bispecific Antibody, Improves Progression-Free Survival in Squamous NSCLC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE81SEFYS2gxSTZKQm9HcmNXMHhuckxMYmVld3RFWnNPbVpIVUszeGh4Wk9lbm53NnF5aXFNd1VSZEhjWGlacUM4RDVEdHR6WXVwa0pJWlpycTJSNUJQUHprRlZlUmZVbUFSU2pWUEtR0gFyQVVfeXFMUDhwRk9UR3ZKZUxMVGdpQVRFY0dzSWRrXzNNNzVNRWxNY0xCenFOWE5QdHliTFcxaHU4cUdLMGxDQi1GMTM0ZHF0bmozaWlxM0tnbUdpVUN3MEszSDBEMkEyaExyUFhUUTFlWUp5bVZFam5R?oc=5","date":"2025-02-14","type":"earnings","source":"koreabiomed.com","summary":"Eutilex’s revenue surge driven more by IT acquisition than biotech growth - koreabiomed.com","headline":"Eutilex’s revenue surge driven more by IT acquisition than biotech growth","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5ZZGUtMndZYnpMdGxpN09scjhxM3B2WUhDcjZ0a3pMNGwwVEZwRl9FcWV0bGYtNVJSeWdkemViN1F3dkFuY1B4QS1WNjliMGhZNlFKYkxFSTRTN2FESzV3aWQ5cjVaRWlTSkRwcm5R0gFyQVVfeXFMTjVEQmN0NFByVV9rOUdNTnZfalJhUnVjNGowR3pHZkEzYjQ2TUFEZnFBTXNGZGpjVlpVWUwzcU5WZ1NpdG1JcHNmTzZYRmFQc3BneGJ0dGtHZnBNLThtQTA3ZXJ0dkx6SGhZeWgxR0Y1Z2J3?oc=5","date":"2023-02-16","type":"pipeline","source":"koreabiomed.com","summary":"Eutilex makes 1st foray into homegrown CAR-T therapy testing - koreabiomed.com","headline":"Eutilex makes 1st foray into homegrown CAR-T therapy testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9RWXhFTTM3aDN6MGpzZ0Q2YzU0cU9TUE1YeE5zLTNXY2had3ZkMUp6WlBmLUkxRWNQdzRfaE1tUV9hQU5LLVUxdnJsZEsyQzFsLWlwa3plREcxd0VLWXhJZ0hjZmhQRUM2SnktMVBB0gFyQVVfeXFMTXdqMGE5VUoyNW94TkxUOVAySmM1OWtjbXUtZEttZE5DNF9faE9YaTlZc2dnSlNmUUx6QjEzT2RLMjU1eVA4VEJVZzZvVjUxSlZMaTJxNWRjX0w0YlJNYmdZNms0Y3psTW9pNWNKaTBZMnNR?oc=5","date":"2022-06-10","type":"trial","source":"koreabiomed.com","summary":"Eutilex to start Korea’s 1st clinical trial for CAR-T in treating solid cancers - koreabiomed.com","headline":"Eutilex to start Korea’s 1st clinical trial for CAR-T in treating solid cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNMV9IMDNSdFBpcWdmUnlTRERuQXZPaGdjX0huUDJTa3p4R3NWaHpzdTh0VVhoQ0E4dl9kc200Y3ZKdHFSalg2MVQ1U3Y4MnJUOTZ2WWM2MWwxZHBlX0ZNVWpqUjlOV0hudHAzNWR0amxwSm1lcFBDSnR0TTZoQ3ZNYWhmRXFLYk56aWplWGNrVXh2d0xTc2RrUFdzNWgyZw?oc=5","date":"2016-12-08","type":"trial","source":"Fierce Biotech","summary":"Eutilex gains $18.9M in Series A round, boosting I/O trial funds - Fierce Biotech","headline":"Eutilex gains $18.9M in Series A round, boosting I/O trial funds","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}